Cargando…
Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267539/ https://www.ncbi.nlm.nih.gov/pubmed/31186609 http://dx.doi.org/10.1007/s40267-018-0576-1 |
| _version_ | 1783376097987002368 |
|---|---|
| author | Heo, Young-A |
| author_facet | Heo, Young-A |
| author_sort | Heo, Young-A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6267539 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62675392018-12-11 Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA Heo, Young-A Drugs Ther Perspect Correction Springer International Publishing 2018-11-17 2018 /pmc/articles/PMC6267539/ /pubmed/31186609 http://dx.doi.org/10.1007/s40267-018-0576-1 Text en © Springer Nature 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Heo, Young-A Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA |
| title | Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA |
| title_full | Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA |
| title_fullStr | Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA |
| title_full_unstemmed | Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA |
| title_short | Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA |
| title_sort | correction to: andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the usa |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267539/ https://www.ncbi.nlm.nih.gov/pubmed/31186609 http://dx.doi.org/10.1007/s40267-018-0576-1 |
| work_keys_str_mv | AT heoyounga correctiontoandexanetalfainthetreatmentofacutemajorbleedingrelatedtoapixabanandrivaroxabanaprofileofitsuseintheusa |